Stocks
Health Care
spro
Spero Therapeutics
NASDAQ: SPRO
+0.11 (+5.02%)
2.3
USD
At close at Mar 04, 21:36 UTC
Income Statement
Revenue
47.98M
Gross Profit
47.98M
Operating Income
-73.36M
Pretax Income
-43.55M
Net Income
-68.57M
EBITDA
-68.56M
EBIT
-68.57M
Earnings Per Share
-1.27
Balance Sheet
Cash & Cash Equivalents
68.74M
Total Debt
4.78M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
72.09M
Book Value Per Share
1.33
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.